Immunogenicity and Reactogenicity of a Single Dose of Live Attenuated Varicella Vaccine and a Booster Dose of Measles-Mumps-Rubella Vaccine Given Concomitantly at 12 years of Age

By Parment Per Arne   Svahn Anita   Rudén Ulla   Bråkenhielm Görel   Storsaeter Jann   Åkesson Lena   Linde Annika  

Scandinavian Journal of Infectious Diseases, Vol. 35, Iss. 10, 2003-10 ,pp. : 736-742

Informa Healthcare

Access to resources Recommend Favorite

Long-term effectiveness of plasma-derived hepatitis B vaccine 22–28 years after immunization in a hepatitis B virus endemic rural area: is an adult booster dose needed?

By  

Epidemiology and Infection, Vol. 145, Iss. 5, 2017-04 ,pp. : 887-894

Cambridge University Press

Access to resources Recommend Favorite

Excellent Booster Response 4–6 y after a Single Primary Dose of an Inactivated Hepatitis A Vaccine

By Iwarson Sten   Lindh Magnus   Widerström Lena  

Scandinavian Journal of Infectious Diseases, Vol. 34, Iss. 2, 2002-02 ,pp. : 110-111

Informa Healthcare

Access to resources Recommend Favorite

Immunogenicity and Reactogenicity of a New Measles, Mumps and Rubella Vaccine When Administered as a Second Dose at 12 y of Age

By Gothefors Leif   Bergström Erik   Bäckman Margareta  

Scandinavian Journal of Infectious Diseases, Vol. 33, Iss. 7, 2001-07 ,pp. : 545-549

Informa Healthcare

Access to resources Recommend Favorite

Safety and Immunogenicity of Combined DTPa-IPV Vaccine for Primary and Booster Vaccination

By Meriste Sirli   Tamm Eda   Willems Paul   Lutsar Irja  

Scandinavian Journal of Infectious Diseases, Vol. 31, Iss. 6, 1999-12 ,pp. : 587-591

Informa Healthcare

Access to resources Recommend Favorite